Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV), a member of the coronavirus family, caused the SARS epidemic in 2002-2003. Rapid and specific serological assays are crucial for diagnosis, epidemiological surveillance, and immunological studies regarding SARS-CoV infections.
The SARS-CoV ELISA Kit is an immunoassay designed to qualitatively and quantitatively detect human antibodies (IgG and/or IgM) specific to SARS-CoV antigens in serum, plasma, or other biological samples. These kits provide essential tools for assessing exposure, immune response, and vaccine efficacy.
Performance Characteristics
- Sensitivity: High analytical sensitivity enables detection of low antibody levels.
- Specificity: Designed to minimize cross-reactivity with other human coronaviruses and related pathogens.
- Reproducibility: Low intra- and inter-assay coefficient of variation ensures consistent, reliable results.
Applications
- Diagnosis of SARS-CoV infection by detecting specific antibody responses.
- Seroprevalence studies to assess population exposure.
- Evaluation of immune responses post-vaccination or natural infection.
- Research in SARS-CoV pathogenesis and immunology.
SARS-CoV ELISA Kits offer sensitive, specific, and practical methods for detecting human antibodies to SARS-CoV proteins. They serve as indispensable tools for clinical diagnostics, epidemiological surveillance, and research aiming to understand and control SARS coronavirus infection.
